Showing results (491-500 of 694) with videos related to
Sort By:
Pageof 70
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 16, 2023
Development of an Automated Capillary Immunoassay to Detect Prion Glycotypes in Creutzfeldt-Jakob DiseaseJennifer Myskiw, Lise Lamoureux, Anne Peterson, et al.Journal of Molecular and Cellular Cardiology|March 17, 1998
Attenuation of interleukin-8 expression in C6-deficient rabbits after myocardial ischemia/reperfusionK S Kilgore, J L Park, E J Tanhehco, et al.Surgical Neurology|August 1, 1995
Analysis of brain tumors using 1H magnetic resonance spectroscopyD Q McBride, B L Miller, D L Nikas, et al.Journal of Thrombosis and Haemostasis : JTH|February 26, 2010
Activation of single-chain urokinase-type plasminogen activator by platelet-associated plasminogen: a mechanism for stimulation of fibrinolysis by plateletsK M Baeten, M C Richard, S M Kanse, et al.Blood|October 22, 2014
Functional factor XIII-A is exposed on the stimulated platelet surfaceJoanne L Mitchell, Ausra S Lionikiene, Steven R Fraser, et al.American Journal of Physiology. Endocrinology and Metabolism|December 18, 2002
IGF-I and IGFBP-3 transport in the rat heartMary Boes, Brian L Dake, Barbara A Booth, et al.Journal of Cardiovascular Pharmacology|July 21, 1999
Reduction of myocardial infarct size after ischemia and reperfusion by the glycosaminoglycan pentosan polysulfateE J Tanhehco, K S Kilgore, K B Naylor, et al.Plos One|February 25, 2012
MicroRNA 146a (miR-146a) is over-expressed during prion disease and modulates the innate immune response and the microglial activation stateReuben Saba, Shantel Gushue, Rhiannon L C H Huzarewich, et al.Pharmacology|February 2, 1999
N-Acetylheparin pretreatment reduces infarct size in the rabbitJ L Park, K S Kilgore, K B Naylor, et al.Experimental Nephrology|November 1, 1993
Effect of transforming growth factor-beta 1 on plasminogen activators and plasminogen activator inhibitor-1 in renal glomerular cellsH M Wilson, F J Reid, P A Brown, et al.Pageof 70